Loading categories...
Advocacy Groups

The Diversity Action Plan debate, explained for advocacy groups
A federal rule that was supposed to make clinical trials more representative of the people...

Master protocols in rare disease research: why one study can serve many patients
A rare disease is one that affects fewer than 200,000 people in the United States. The Nat...

Synthetic control arms and placebos: what advocacy groups can teach their communities
Placebo fear is one of the most common reasons people turn down a clinical trial. Communit...

How advocacy groups can lead community pre-screening for clinical trials
Advocacy groups have always sat close to the people clinical research most needs to reach....

How patient advocacy groups turn registries into clinical trial referrals
A patient registry is one of the most valuable assets an advocacy group holds. It represen...

What Advocacy Groups Should Look For in a Patient Recruitment Platform
Advocacy organizations occupy a rare seat at the table. Community members turn to disease ...
Page01of04
